Fintech Firm Blend Labs Seeks US$360 Million In IPO

Blend Labs Inc. announced this morning the launch of its initial public offering on the New York Stock Exchange. The company will be offering 20.0 million Class A stocks on the big board under the symbol “BLND”.

The offering price is expected to be between US$16.00 to US$18.00 per share for potential total aggregate proceeds of up to US$360.0 million. The financial software company also gave the underwriters a 30-day option to purchase an additional 3,000,000 common shares.

In the prospectus filed, the San Francisco-based fintech company recorded US$31.9 million in revenue and a US$27.1 million net loss for Q1 2021. The company also raised US$300.0 million in its last round of funding in January 2021, putting the company’s valuation at US$3.3 billion. The proposed public offering seeks to bring this up to US$3.95 billion.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Goldman Sachs & Co., Allen & Company, and Wells Fargo Securities are all managing the offering as lead underwriters. 


Information for this briefing was found via Blend. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Red Cloud Fall Mining Showcase 2026 | Day 2

More Gold Without a Bigger Upfront Bill? | Keith Boyle – New Found Gold

The Red Cloud Fall Mining Showcase 2026 | Day 1

Recommended

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Meghan Markle’s Half-Brother Submitted Evidence Against Their Father, But Now Faces Philippine Police Scrutiny

Related News

Circle Files for U.S. IPO to Bring Stablecoin USDC to Public Markets

Boston-based Circle Internet Financial, the driving force behind the widely-used stablecoin USDC, has confidentially filed...

Thursday, January 11, 2024, 09:29:00 AM

Did Nasdaq Rewrite Its Index Rules for SpaceX?

Nasdaq adopted a sweeping overhaul of its Nasdaq-100 methodology in March 2026, effective May 1...

Monday, June 1, 2026, 05:43:36 AM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

Internet Business SPAC Worldwide Webb Acquisition Prices US$200 Million IPO

Special purpose acquisition company Worldwide Webb Acquisition Corp. (Nasdaq: WWAC.U) started trading publicly on the...

Wednesday, October 20, 2021, 02:26:00 PM